Podcasts about trials

Gratitude is rarely our first instinct when we’re hurting. In today's prayer and devotional, seasons of loss, grief, or overwhelming uncertainty often make thankfulness feel impossible. Keri Eichberger shares the story of her miscarriage nearly 20 years ago—a season filled with deep pain, grief, and a desperate attempt to regain control. Looking back, she realizes how little gratitude she expressed during that time and how much peace she forfeited by striving instead of surrendering. Philippians 4:6-7 reminds us that the pathway to peace is not simply prayer, but prayer with thanksgiving. Gratitude in trials isn’t pretending things aren’t painful; it’s acknowledging God’s presence, goodness, and care—right in the middle of our suffering. Thanksgiving guards our hearts and minds, creating space for the supernatural peace we long for but cannot manufacture on our own. When we thank God—even through tears—we declare by faith that He is working, that He has purpose in our pain, and that His goodness will follow us all the days of our lives. Gratitude doesn’t erase grief, but it anchors us in the truth that God is with us, carrying us, strengthening us, and offering peace the world cannot give. Today's Bible Reading:“Do not be anxious about anything, but in every situation, by prayer and petition, with thanksgiving, present your requests to God. And the peace of God, which transcends all understanding, will guard your hearts and your minds in Christ Jesus.” – Philippians 4:6-7 Takeaway Truths Gratitude is a spiritual discipline that guards our hearts with God’s peace. Peace does not come from control—it comes from surrender. God offers blessings, presence, and purpose even in seasons of deep pain. Let’s Pray Father God, You are my ever-present peace. And though I can become consumed with control, worry, or whatever it is I wish were different, still I know You are there. You are there with perfect peace and boundless blessings, and I am so grateful. Lord, help me acknowledge Your presence. Help me see Your goodness. And help me never forget to express my gratitude to You. You are the giver of all good things; You never stop pouring them out over my life, and I praise You for Your presence and peace that transcend all understanding. In Your Almighty Name, Amen. Related Scriptures 1 Thessalonians 5:18 James 1:2-4 Psalm 34:18 Isaiah 26:3 Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Free Vs Investment Trials: Why a $1 Trial Can Be More Powerful Than a Free Trial with Favour Obasi-Ike | Sign up for exclusive SEO insights.This Clubhouse audio session focused on marketing strategies, specifically comparing the efficacy of free trials versus investment trials for products and services. Favour discusses how an investment trial, even as low as one dollar, establishes a financial commitment from the customer, potentially leading to better conversion than a completely free offer, though both require nurturing efforts. The conversation also touches on upcoming holiday sales, various email marketing platformslike Flowdesk, and the importance of technical SEO and website development in business growth. Ultimately, Favour advises business owners to analyze and decide which trial method best suits their goals, emphasizing that the psychology of value is crucial for long-term customer engagement.--------------------------------------------------------------------------------Next Steps for Digital Marketing + SEO Services:>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Need SEO Services? Book a Complimentary SEO Discovery Call with Favour Obasi-Ike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> Visit our Work and PLAY Entertainment website to learn about our digital marketing services.>> Visit our Official website for the best digital marketing, SEO, and AI strategies today!>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our exclusive SEO Marketing community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> Read SEO Articles>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Need SEO Services? Book a Complimentary SEO Discovery Call with Favour Obasi-Ike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to the We Don't PLAY Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠--------------------------------------------------------------------------------Introduction: The "Free Trial" FallacyOffering a "free trial" is a universal business strategy, especially during peak seasons like Black Friday or the holidays. It's the go-to method for attracting customers by lowering the barrier to entry. But have you ever considered that "free" might not be the most effective path to gaining truly committed customers?This article explores a few surprising truths about customer psychology and commitment by comparing the standard free trial with a powerful alternative: the "investment trial." We'll examine why asking for a small, initial investment can fundamentally change the customer relationship and lead to better results.The Surprising Takeaways from Free vs. Investment Trials1. The Power of a Single Dollar: Shifting from a "User" to an "Investor" MindsetThe core difference between a "free trial" and an "investment trial" is the financial commitment. A free trial has none, while an investment trial requires a small payment, even if it's just $1. This seemingly minor detail triggers a significant psychological shift.When a customer pays—even a nominal amount—their mindset changes. They are no longer a passive user getting something for free; they have become an active investor in a potential solution. This act pre-qualifies them and changes their relationship with the product from the very beginning. Because they have invested, they are more likely to perceive the engagement as a "better experience," reinforcing the value of their decision and anticipating an even greater return on a larger future investment....if you now say, okay, it's $99 or it's $1,000 or it's whatever amount of dollars, the person doesn't feel like they have to think twice about started because they've already financially committed to something that was an investment that they were interested in. That's the difference.This initial commitment dramatically shortens the time it takes to convert a trial user into a full-paying customer. The journey from a $1 investment to a $1,000 purchase is psychologically shorter than the journey from "free" to any paid plan. While a free trial may require 14 to 30 days of nurturing to achieve conversion, an investment trial can convert in as little as 10 minutes or one hour because the primary psychological barrier has already been crossed.2. The Real Cost of "Free" Isn't Zero—It's TimeNothing is truly free. In a free trial, the user isn't paying with money, but with an equally valuable currency: their time and attention.When someone engages with a free product, they are spending time processing information and making a decision. The business's goal is to make that time investment feel so valuable that it leads to a financial one. Think of the common B2B strategy of offering a free 30-45 minute consultation call. The prospect invests their time, and in exchange, the business must deliver enough tangible value in that short window to justify a larger investment. The "free" call becomes a sale because the value demonstrated makes the time spent feel worthwhile. The same principle applies to tasting a free food sample—if it delivers immediate value, it leads to a purchase.So if it's a free trial, yes, get it for free. Sign up for free... it's not really free because they're spending time. That's the exchange.The implication for businesses is clear: the product or information offered in a free trial must deliver immediate, tangible value. You must make the user's time investment feel so worthwhile that they are compelled to make a financial one.3. The $2,000 Anomaly: Why High-Ticket Sales Can Be Easier Than Low-Ticket OnesOne of the most surprising claims is that "it's harder for me to sell a $20 product than a $2,000 product." This paradox defies conventional business logic, but the reasoning behind it is sound.Customers often perceive small, recurring payments as nuisances or minor expenses they'd rather avoid. In contrast, they view large, one-time investments as significant projects with a high potential return. A high-ticket investment is tied to a bigger, more valuable outcome—such as achieving AI SEO, building websites, gaining domain authority, or becoming dominant in your area of expertise—that they can justify more easily as a strategic move.This connects directly back to the "investment trial" concept. A person willing to invest just $1 is already thinking about potential returns, which is the exact mindset needed to make a larger, high-value purchase. They have already crossed the mental barrier from being a passive consumer to an active investor.This should encourage you to reconsider your pricing and offer structure. Instead of focusing only on low-cost entry points, consider how to frame your offerings as high-value investments that solve significant problems for your ideal customers.Conclusion: Your Next MoveThe psychology behind a trial offer is often more critical than the price tag. The ultimate goal isn't just to get sign-ups; it's to cultivate an investor's mindset from the very first interaction. By asking for a small commitment, you attract a more serious audience and prime them for a long-term, high-value relationship.As you plan your next offer, ask yourself this: How can you shift the focus from a simple "free sample" to a meaningful "initial investment" to attract your most committed future customers?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Featuring: Ammosart, Ashgar, Belghast, Grace, Kodra, Tamrielo, and Thalen   Hey Folks! We recorded a massive show where we effectively burned through our entire backlog of topics.  We start off talking about the new character, Maru, in Destiny Rising, and how this seems to be leading us to finally getting off the planet.  Kodra discusses Broom Sweeper, which is effectively the Roguelikeification of Minesweeper.  Bel got sucked into a local pen and paper game for Public Access and talks a bit about the setting.  Ash is doing a "Three Job Fiesta" run of Trials of Mana, and Tam has been playing some ArcRaiders.  We are all pretty pumped for the announcement of new Steam Hardware and what this means for PC gaming.  Kodra and Tam talk about It Takes a War, and Bel revisits his Freezy Boom character in Path of Exile.  We wrap up the show with some rapid-fire discussions about Gunfire Reborn, Winter Burrow, and Ambrosia Sky.   Topics Discussed: Destiny Rising Pirate Queen Maru Broom Sweeper Public Access TTRPG Trials of Mana Three Job Fiesta Arc Raiders More Steam Hardware It Takes A War Path of Exile Freezy Boom Revisited Gunfire Reborn Winter Burrow Ambrosia Sky

Msgr. Roger J. Landry Convent of the Missionaries of Charity, Bronx, NY Thirty-Third Sunday in Ordinary Time, Year C World Day of the Poor November 16, 2025 Mal 3:19-20, Ps 98, 2 Thes 3:7-12, Lk 21:5-19   To listen to an audio recording of this homily, please click below:  https://traffic.libsyn.com/secure/catholicpreaching/11.16.25_MCs_Homily_1.mp3   The following text guided […] The post Persevering With Faith and Hope through Trials, 33rd Sunday (C), November 16, 2025 appeared first on Catholic Preaching.

It's World AMR Awareness Week (WAAW) and we have prepared a special episode in light of that. In this week's Communicable, Navaneeth Narayanan and Thomas Tängdén host Aula Abbara (London, UK), Guido Granata (Rome, Italy) and Tuomas Aro (Helsinki, Finland) to discuss the phenomenon of AMR in conflict and crisis zones. They elaborate on how difficult conditions and austere environments amplify the spread of AMR, drawing on findings from the ongoing conflicts in Ukraine, Gaza, Syria and other regions. Other topics covered include adapting antimicrobial stewardship and infection prevention and control (IPC) practices as well as the need for genuine political will and international collaboration to end conflicts and their exacerbation on AMR.This episode follows the webinar “Beyond the frontlines” organised by ESCMID's AMR Action Subcommittee for WAAW 2025, featuring the same guests, and is available on ESCMID Media. This Communicable episode was peer reviewed by Arjana Zerja of Mother Theresa University Hospital Centre, Tirana, Albania.  Related ESCMID and Communicable mediaESCMID Media, Part 1: Beyond the frontlines - tackling AMR in conflict and crisis zones, webinar Communicable episode 11: Nightmare series, part 2 – how to deal with carbapenemase producers Communicable episode 16: Climate change and infections – effects on clinical practice & sustainabilityResourcesTrainee Association of ESCIMD (TAE) Doctors without Borders (Médecins sans Frontières), Antibiogo, https://www.antibiogo.org/Doctors without Borders (Médecins sans Frontières), Mini-lab, https://fondation.msf.fr/en/projects/mini-lab Further ReadingAbbara A, et al. Unravelling the linkages between conflict and antimicrobial resistance. NPJ Antimicrob Resist. 2025. DOI: 10.1038/s44259-025-00099-yAbbara A, et al. A summary and appraisal of existing evidence of antimicrobial resistance in the Syrian conflict. Int J Infect Dis. 2018. DOI: 10.1016/j.ijid.2018.06.010Abu-Shomar R, et al. Multidrug-resistant Pseudomonas isolated from water at primary health care centers in Gaza, Palestine: a cross-sectional study. IJID Reg. 2025. DOI: 10.1016/j.ijregi.2025.100671Aldbis A, et al. The lived experience of patients with conflict associated injuries whose wounds are affected by antimicrobial resistant organisms: a qualitative study from northwest Syria. Confl Health. 2023. DOI: 10.1186/s13031-023-00501-4Aro T, et al. War on antimicrobial resistance: high carriage rates of multidrug-resistant bacteria among war-injured Ukrainian refugees. Clin Microbiol Infect. 2025. DOI: 10.1016/j.cmi.2025.07.010  Bazzi W, et al. Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms. Front Microbiol. 2020. DOI: 10.3389/fmicb.2020.00068 Dewachi O. War Biology and Antimicrobial Resistance: The Case of Gaza, AMR Insights, 2024.Granata G, et al. The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clin Microbiol Infect. 2024. DOI: 10.1016/j.cmi.2024.03.029 Huang XZ, et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect. 2012. DOI: 10.1017/S0950268811002871Hujer KM, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006. DOI: 10.1128/AAC.00778-06Karah N, et al. Teleclinical Microbiology: An Innovative Approach to Providing Web-Enabled Diagnostic Laboratory Services in Syria. Am J Clin Pathol. 2022. DOI: 10.1093/ajcp/aqab160Keen EF 3rd, et al. Evaluation of potential environmental contamination sources for the presence of multidrug-resistant bacteria linked to wound infections in combat casualties. Infect Control Hosp Epidemiol. 2012. DOI: 10.1086/667382Murray CK, et al. Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. Mil Med. 2009. DOI: 10.7205/milmed-d-03-8008Petersen K, et al. Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. J Clin Microbiol. 2011. DOI: 10.1128/JCM.00766-10Scott P, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007. DOI: 10.1086/518170Sensenig RA, et al. Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties. Am J Infect Control. 2012. DOI: 10.1016/j.ajic.2011.03.025World Health Organization. Fourth WHO Global Evidence Review on Health and Migration stresses that equitable access to and appropriate use of antibiotics for refugees and migrants is essential to tackling Antimicrobial Resistance, News, 2022.

In today's devotional, Dr. Michael A. Youssef calls us to holy devotion of Christ, our righteousness.If you would like more insight into today's devotional topic, listen to Dr. Michael A. Youssef's sermon series Got Freedom?: LISTEN NOW

What if you fall in love on the brink of death? Singing Through Fire (Isaiah 4320 Press, 2025) invites readers into the Job-like true story of a young woman who loses everything-and dares to ask why a good God allows it. When Stanford Law graduate Lara Palanjian collapses on her dream job, she never imagines it will lead to four years bedridden-or to the love of her life. Enter Matthew Silverman: a witty, wise, and impossibly joyful youth pastor and professor facing terminal cancer. What begins with a few random encounters soon ignites an extraordinary, God-written love story that neither of them saw coming. As their unlikely romance unfolds between medical crises, late-night laughter, and unexpected musical performances, Matthew's unshakable faith challenges everything Lara thinks she knows about God's goodness-and what it means to walk with Christlike faith, resilience, and joy in the face of overwhelming grief and suffering. But with time against them, one question looms louder than the rest: What if this gift is only for a moment? Surprisingly funny and spiritually rich, Singing Through Fire is a modern-day "Job meets Lucille Ball." It explores what it means to suffer, love, and even laugh and make music while your life is burning down around you. It eloquently gives voice to the aching questions many sufferers quietly carry-then takes readers inside the breathtaking story of two people who found miraculous love and defiant joy amid heartbreaking loss. It reveals how God can use even our deepest pain to write the most beautiful love stories-even on the cusp of eternity.Find and follow Lara on IG: here Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Do the many clinical trials into high-dose vitamin C prove it can actually treat the common cold and cancer, rather than just boost the immune system? Why is there ongoing scepticism? Why are multifactorial chronic diseases so hard to study in clinical trials? What is the right dosage to get the best results from vitamin C?In this episode we have the often misunderstood topic of Vitamin C as an antioxidant to get clear on, particular the high-dose approach and particularly delivered intravenously. Despite a very clear consensus that Vitamin C is a great booster to immune function, research that shows that it helps fight the common cold or flu have been dismissed by doctors and medical researchers; as well as claims that higher doses can increase its efficacy. Other claims that Vitamin C can help fight cardio-vascular disease and even cancer have been with even greater scepticism. So what exactly can vitamin C do to assist our immune function to fight disease, and why is there so much confusion about the answer given the high quantity of clinical trials data?Fortunately today's guest has exactly the right skill set and research knowledge to separate the science from the here-say, medical doctor and orthomolecular medicine researcher, Dr. Richard Z Cheng. Dr. Cheng has a PhD in biochemistry and molecular biology; he's served as a doctor in the US military; he has consulted for the National Cancer Institute, and presented at the National Institute of Health (NIH); he has conducted clinical trials; He is the editor in Chief of the Orthmolecular Medicine New Service; He is also a fellow of the American Academy of Anti- Aging medicine; and has run anti-aging and regenerative medicine clinics in both China and the US for over 20 years.What we discuss:00:00 Intro05:15 Most animals produce Vitamin C in the body, but not primates.06:00 Oxidation & Redox: Giving or receiving an electron.11:00 After reducing oxidation the body recycles it back into vitamin C.14:00 Teamwork: sharing electrons between nutrients and vitamins.18:20 Conventional consensus: good for prevention but not treatment.21:00 Over 80K papers on Vit C on Pub Med!21:30 Linus Pauling Intravenous Vitamin C for cancer and heart disease.27:00 Shortening of common cold and lowering of symptoms - Harri Hemila.29:00 Low dose studies dilute the data on the efficacy of the high dose studies.31:00 Intravenous treatment allows much higher doses safely.33:00 Differences in absorption between IV and oral application.35:20 Pro-oxidant effect only possible at IV high dose.36:30 IV clinical trials.39:20 Cytokine storm cascades in acute respiratory distress.44:00 High Dose IV Vitamin C saved lives in China during Covid 19.50:00 Attacks following Richard's NIH presentation on Vitamin C during covid.57:00 Cardio vascular disease - Vit. C research history.01:01:00 Collagen Synthesis for vascular walls & Vitamin C deficiency.01:07:20 Is the taboo for life style medicine lifting?01:09:30 Issues of gold standard RCT trials not working for multifactorial integrative interventions.01:16:00 Recommendations for preventative use of Vitamin C for listeners. References:E Cameron & Linus Pauling - 'Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer', 1976E.T. Creagan, 'Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer', 1979Harri Hemilä - over 200 meta-analyses and clinical trialsPing Chen et al. 'Pharmacokinetic Evaluation of Intravenous Vitamin C'Richard Z Cheng, ‘Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?'KU Cancer Center researchers announce study of high-dose intravenous vitamin C to treat muscle-invasive bladder cancer, 2024National Cancer Institute overview of IV Vitamin C cancer research.

Would this be described as a difficult time for you? Maybe you're one of the many who is really struggling financially right now? Or perhaps your marriage is falling apart or you're really discouraged about what's going on in the world around you! When times are tough, the book of First Peter is a good place to turn for hope and encouragement. And that's where we're headed today and in the coming weeks on a Daily Walk. Trials are a part of life, and something we all encounter. We'll show you how to go through them, while maintaining a godly perspective! To support this ministry financially, visit: https://www.oneplace.com/donate/1368/29?v=20251111

Standing Firm on a Shaky World -Rejoicing in Trials - 1Peter 4:12-19

In this episode of TishTalk, I speak with Ray McGinnis, Author of "Unjustified" and Donna Laframboise, Author of" Thank you Truckers" about the on-going persecution of the freedom convoy protesters and the shameful state of Canada's judicial system.

What if you fall in love on the brink of death? Singing Through Fire (Isaiah 4320 Press, 2025) invites readers into the Job-like true story of a young woman who loses everything-and dares to ask why a good God allows it. When Stanford Law graduate Lara Palanjian collapses on her dream job, she never imagines it will lead to four years bedridden-or to the love of her life. Enter Matthew Silverman: a witty, wise, and impossibly joyful youth pastor and professor facing terminal cancer. What begins with a few random encounters soon ignites an extraordinary, God-written love story that neither of them saw coming. As their unlikely romance unfolds between medical crises, late-night laughter, and unexpected musical performances, Matthew's unshakable faith challenges everything Lara thinks she knows about God's goodness-and what it means to walk with Christlike faith, resilience, and joy in the face of overwhelming grief and suffering. But with time against them, one question looms louder than the rest: What if this gift is only for a moment? Surprisingly funny and spiritually rich, Singing Through Fire is a modern-day "Job meets Lucille Ball." It explores what it means to suffer, love, and even laugh and make music while your life is burning down around you. It eloquently gives voice to the aching questions many sufferers quietly carry-then takes readers inside the breathtaking story of two people who found miraculous love and defiant joy amid heartbreaking loss. It reveals how God can use even our deepest pain to write the most beautiful love stories-even on the cusp of eternity.Find and follow Lara on IG: here Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/christian-studies

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Curtis Green, better knows by OG bitcoiners as "Chronicpain" or "Flush", is a former forum moderator and website administrator of the Silk Road internet marketplace. He is a man who has mined bitcoin early enough to get scammed by Butterfly Labs, and was allegedly also the target of a bounty on assassination markets. He's seen all eras of Bitcoin, and today he seeks to get pardoned by the Trump administration. He will accept donations from community members in order to get the legal help he needs. Read Curtis Green's book, "Silk Road Takedown": https://www.amazon.com/dp/1729436889 Donate to Curtis Green: https://www.satlantis.io/events/1210/Evening-with-OG-Curtis-Green%2C-admin-of-The-Silk-Road Time stamps: 00:01:18 Welcome Curtis Green, Silk Road OG 00:02:06 Seeking Clemency, Focus Shift from Ross 00:04:02 Misnomers, Site Rules & Govt Narrative 00:07:27 Bitcoin Skepticism, Forum Learning 00:11:02 PGP/Key Lessons 00:13:04 Harm Reduction Suggestion, Forum Admin 00:15:23 Freedom Emphasis, Site Growth Post-Schumer 00:17:00 Bitcoin as Freedom Tool 00:21:36 Verify Mindset 00:22:59 Mining & Gifting BTC, Family Rejection 00:26:01 Price Doubts, Ethereum Shift 00:29:02 Arrest Warning 00:33:40 Mining Fun 00:36:02 When Schumer Promoted Silk Road 00:38:17 Arrest Story, Corrupt Agents 00:39:55 BTC Theft by Shaun ridges 00:43:04 Faked Torture, Murder Threat 00:45:04 Playing Dead for 10 Months 00:48:03 Narrative Control, Cash Seizure 00:51:21 Limited DPR Info, Accusations 00:53:28 Site Takedown, Personal Hell 00:55:00 Family Struggles, Entrepreneurship 00:57:12 Book & Documentary Distortions 00:59:45 Corrupt Agents' Trials 01:02:30 Force's Extortion Attempts 01:05:15 Bridges' Theft Details 01:07:50 Sentencing, No Prison 01:10:20 Clemency Petition 01:13:45 Bitcoin Evolution Reflections 01:16:10 Mining Zcash, Privacy Views 01:19:30 Early Bitcoin Doubts 01:22:45 Forum Discussions, Community 01:25:00 Harm Reduction Impact 01:27:30 Global Revolution Hopes 01:32:03 Consensus & Debates 01:34:02 Aha Moments 01:39:01 Narrative Shaping Power 01:41:23 Life Experiences Gratitude 01:43:37 Speaking Out, Misjudgments 01:45:03 Educating on Crypto Choices 01:46:00 Future Optimism 01:47:32 Educators like Antonopoulos 01:49:52 Community Support Moments 01:52:07 Bitcoin Changes Narrative 01:53:02 Lightning Node Experience 01:55:55 Lightning Hopes & Issues 01:57:05 Wrapped BTC Concerns 01:59:14 WBTC on Ethereum Popularity 02:00:14 Block Size Debates 02:02:07 Satoshi's Scaling Views 02:04:33 Lightning Limitations 02:06:00 Scaling Consensus Challenges 02:08:44 Roger Ver's Unity Point 02:10:10 Early Empty Blocks 02:12:04 Zcash Proposal for Bitcoin 02:14:03 Sponsors: NoOnes & SideShift 02:16:42 ShapeShift Confusion 02:18:00 Tunnel Vision on BTC Amounts 02:18:07 Bitcoin Changes & Consensus Hopes 02:18:30 ETFs Caution, Mainstream Adoption 02:19:33 Peer-to-Peer Origins, Early Exchanges 02:20:05 Postal Money Orders for BTC 02:21:02 Alpaca Socks & Honey Purchases 02:21:49 Early BTC Buys, Galaxy Tab Scam 02:23:15 BTC as Tool, Not Dollars 02:24:01 Holding vs Spending 02:26:00 Early Satoshi Discussions 02:27:27 Adoption Decline Rant 02:28:22 BTC Scarcity & Usage 02:29:03 Layer 2 Hopes, Wife's Worries 02:30:05 Mining Challenges Over Time 02:31:03 Still Early in Bitcoin? 02:32:25 Satoshi's Blueprint, Competition 02:33:30 First Bitcoin Encounter 02:34:51 Silk Road Catalyst for BTC 02:35:25 Rabbit Hole Journey 02:36:31 Govt Op Doubts Nixed 02:37:02 Aha Moment in 2012 02:38:00 Grateful for Silk Road Lessons 02:39:02 Bad Rap Focus on Drugs 02:40:47 Pinnacle in BTC History 02:41:29 Speaking Out & Education 02:42:03 DPR's Clean Water Ideas 02:43:00 Zcash Mining Hype & Launch Supply Dynamics 02:45:01 Keeping ZEC, Mining Costs 02:46:09 Buying vs Mining Regrets 02:47:11 Hindsight on Holding 02:48:31 ASIC Delivery Post-Arrest 02:49:03 Keeping Quiet on Miners 02:50:07 Side Stories Justification 02:51:03 Mentality Shifts 02:52:17 Hopes for Bitcoin Win 02:53:01 Cultural vs Technical Issues 02:53:46 SegWit & Taproot Changes 02:55:38 Privacy Proposals 02:57:01 Developer Frustrations 02:58:04 Greed & Humanity Balance 02:59:20 Year-by-Year Changes 03:00:04 ETF as Scaling Layer 03:02:05 High Hopes & 21M Cap Worries 03:03:05 Verification Defeat 04:03:30 Genesis Block & Bailouts 04:04:03 Fractional Reserves Drop 04:04:38 ETF Trust Issues 04:04:52 Proof of Keys Celebration 04:05:55 Back to Banks Cycle 04:06:07 Lightning Custodial Wallets & Centralization 04:14:02 Start9 & Braiins BMM Miner 04:18:02 Home Miners Appeal 04:49:44 Guilty Plea Frustrations 04:51:18 AlphaBay Documentary & Monero Adoption 04:52:48 Dark Web Warnings 04:55:32 Trusted Escrows 04:56:47 Bitcoin Talk Scams 04:57:13 Satlantis Donations & Adopting Bitcoin Talk

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "NEALS 2025: Takeaways That Matter for ALS Care," ALS experts Jinsy Andrews, MD, MSc, and James Berry, MD, MPH, reflect on key themes from the 2025 NEALS Annual Meeting, now reintroduced as the Network of Excellence for ALS. They discuss format changes that elevated lightning science, the expanding gene therapy pipeline, and a growing slate of NEALS-affiliated trials. The conversation highlights updates from the HEALEY Platform Trial, the MY-MATCH biomarker-guided precision trial, SOD1 program data, and new antisense and viral vector therapies aimed at sporadic ALS. They also explore the impact of Act for ALS on trial access, the ALL ALS biospecimen repository, and NIH-supported expanded access cohorts. The discussion closes with insights on combination therapy strategies, genetic subtypes, presymptomatic enrollment, and how new collaborations, digital endpoints, and infrastructure advances are shaping momentum heading into 2026. Looking for more Neuromuscular discussion? Check out the NeurologyLive® Neuromuscular clinical focus page. Episode Breakdown: 1:05 – Reflections on meeting highlights and NEALS rebranding into a global network 5:00 – Notable NEALS-affiliated trials and promising new mechanisms in ALS care 12:45 – Combination therapy strategies and future approaches in ALS research 15:20 – Neurology News Minute 18:00 – Expanding clinical trial access for rare and genetic ALS subtypes 22:10 – Building momentum and expectations for the 2026 NEALS Annual Meeting The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation BTK Inhibitor Fenebrutinib Meets Primary End Points in Phase 3 Trials for Both Relapsing and Primary Progressive MS  Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

See omnystudio.com/listener for privacy information.

The first year of retirement is one of life's great paradigm shifts, and approaching it with a level of mindfulness is essential. Donna discusses the psychological hurdles that many face following their transition to retirement, and how to avoid getting tripped up. Also on MoneyTalk, how to reinforce financial goal-setting with young adults, and IRA FAQs. Host: Donna Sowa Allard, CFP®, AIF®; Air Date: 11/10/2025. Have a question for the hosts? Leave a message on the MoneyTalk Hotline at (401) 587-SOWA and have your voice heard live on the air!See omnystudio.com/listener for privacy information.

Sermon Date: 11/12/2025; Pastor Bill Bryson; Scripture Passage: Psalm 127Support the show

I'm a Celeb starts on Sunday, so we thought we'd have a bit of bush tucker trial fun in the studio this morning

Summary In this engaging conversation, Pastor Jackson Lahmeyer shares his remarkable journey from a young pastor to a prominent figure in the political and faith communities. He discusses the challenges he faced during the pandemic, his advocacy for religious freedom, and the importance of finding true happiness amidst trials. Lahmeyer also provides insights into the newly established White House Faith Office and its role in protecting religious liberty and empowering faith-based organizations. The conversation delves into the ongoing spiritual battle between good and evil and reflects on the future of faith in America.In this conversation, Jackson Lahmeyer discusses the biblical prophecies surrounding the end times, including the Great Tribulation, the return of Jesus Christ, and the significance of the Third Temple in Jerusalem. He emphasizes the importance of understanding these events from a Christian perspective, the role of the Antichrist, and the implications for both Jews and Christians. The discussion also touches on America's support for Israel and the moral complexities of prophecy fulfillment.Jackson's LinkNEW BOOK: Chasing After The WindClayton's Social Media LinkTree | TikTok | Instagram | Twitter (X) | YouTube | RumbleTimecodes 00:00 - Intro01:01 - Pastor Jackson Laemeyer's Journey into Politics06:30 - Finding Happiness in Trials and Tribulations14:45 - The Role of the White House Faith Office20:41 - Interfaith Dynamics and Religious Liberty26:45 - The Spiritual War: Light vs. Darkness31:08 - The Vision of New Heaven and New Earth35:09 - Understanding the Great Tribulation39:38 - The Role of the Antichrist47:59 - Support for Israel and Biblical ProphecyIntro/Outro Music Producer: Don Kin IG: https://www.instagram.com/donkinmusic/Spotify: https://open.spotify.com/artist/44QKqKsd81oJEBKffwdFfPSuper grateful for this guy ^NEWSLETTER - SIGN UP HEREBecome a supporter of this podcast: https://www.spreaker.com/podcast/traveling-to-consciousness-with-clayton-cuteri--6765271/support.

As America approaches 250 years, Kevin Freeman and Mike Carter link modern geopolitical and economic risks with themes from Revelation to highlight six urgent “trials by fire.” From the national debt bomb and currency challenges to CBDCs, inflation-driven wealth gaps, demographic decline, and immigration without assimilation, the stakes are high but manageable. They propose constitutional and market-based solutions, including transactional gold and silver (“Pirate Money”), investor alignment, and proactive civic engagement. A neutral, data-driven framework helps assess threats, prepare wisely, and bolster American resilience.

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA could act as a first hit in lung injury, while Dr. Al-Sawaf revealed that patient fitness may not significantly impact the efficacy of targeted CLL treatments. Both studies challenge existing medical assumptions and suggest new approaches to understanding disease mechanisms and treatment responses.Featured ArticlesThe impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLLMitochondrial DNA via recipient TLR9 acts as a potent first-hit in murine transfusion-related acute lung injury (TRALI)

Show NotesKeywords: faith, adversity, growth, trials, God, resilience, personal development, overcoming challengesSummary - In this conversation, Ms. G discusses the importance of facing trials with faith in God. She emphasizes that adversity is a part of personal growth and that God has a purpose for every challenge we face. By confronting our problems with resilience and faith, we can learn and grow from our experiences.TakeawaysGod is doing something in and through you.He will never allow you to suffer without a significant purpose.The key to getting through adversity is to face them.Face them with faith in God.He will not give you more than you can bear.Adversity is essential for personal growth.Running from problems hinders our development.Faith provides strength during tough times.Every challenge has a purpose.Growth comes from overcoming challenges.Faith in Adversity: Finding StrengthThe Purpose of Trials: A Journey of Growth"God is doing something in and through you.""Face them with faith in God.""He will not give you more than you can bear."

Presented in partnership with Cancer Wellness Center, Tempus, and TriCan Health Artificial Intelligence (AI) is reshaping healthcare — helping patients and providers make smarter, more personalized decisions. In this Wellness Wednesday program, experts from Tempus and TriCan Health will explore how AI is being used to support cancer care, enhance communication between patients and doctors, and make clinical trials more accessible.Whether you're newly diagnosed, supporting a loved one, or simply curious about how technology can drive progress, this discussion will break down complex topics in clear, empowering ways.What You'll Learn: How AI tools help physicians and patients analyze complex data and uncover insightsWays technology personalizes care and improves outcomesHow AI is simplifying the process of finding and joining clinical trials

Reach Out: Please include your email and I will get back to you. Thanks!Good morning! Thank you for taking a few minutes to listen. If you are interested in the Daily Bible Devotional, you can find it at the links below:Amazon - (paperback, hardcover, and Kindle)YouTube Video Introducing the ContentFeel free to reach out with any questions: emersonk78@me.comI Peter 1Peter writes to believers scattered across the regions, reminding them of their living hope through the resurrection of Jesus Christ. He praises God for granting an inheritance that is imperishable, undefiled, and reserved in heaven. Trials and suffering are depicted as means to refine faith, which is more precious than gold. Peter emphasizes that salvation has been foretold by the prophets and revealed through Christ. He urges believers to live holy lives, fully setting their hope on the grace to come. As obedient children, they are called to be distinct from the world and to live in reverent fear, knowing they were redeemed by the precious blood of Christ. Peter reminds them that the will of God endures forever and that they have been born again through the living Word.  We are reminded in this passage that our hope is not rooted in anything temporary but in the resurrection of Jesus Christ. Because of this, we can face trials with confidence, knowing that God uses them to strengthen and refine our faith. We are called to live holy and obedient lives, setting ourselves apart from the world and keeping our eyes on the eternal inheritance that awaits us. As we reflect on the cost of our redemption, we are inspired to live in reverent awe of God. We have been born again through His living and enduring Word, and we now have a purpose to live differently. Each day, we strive to reflect His holiness in our thoughts and actions. Gracious Lord, thank You for a living hope through the resurrection of Jesus Christ. We praise You for the inheritance that is kept in heaven for us, pure and everlasting. Help us remain strong through trials, knowing that our faith is being refined and made more precious than gold. Teach us to live holy lives, set apart for Your glory. May we walk in reverent fear, always remembering the great price You paid for our redemption. Let Your Word grow in our hearts and guide our steps daily. Strengthen us to live in obedience and to love one another sincerely. Thought Questions: What has God's mercy and power accomplished for you? Specifically, what is the promised “inheritance”, and how does it guide your life? How do you “prepare your mind for action, keep sober in spirit, and fix your hope completely” on Christ's return on a daily basis? Why is the love of brethren such a central part of living the Word and honoring the sacrifice of Jesus? How do you do this when it is difficult?

We have officially started our month of guests! Please follow Rachel and her socials for more information! Rachel's Instagram: https://www.instagram.com/rachel.elese?igsh=MzRlODBiNWFlZA==https://www.instagram.com/rachel.elese?igsh=MzRlODBiNWFlZA== Rachel's Portfolio: https://www.rachelelese.com/?fbclid=PAb21jcAOBiP1leHRuA2FlbQIxMQBzcnRjBmFwcF9pZA81NjcwNjczNDMzNTI0MjcAAafcFvzUDLMTG4XDTGKPfe7Kvy9sKo0Fl1Vm6r09Z6PyKGryUMoYVYj1ohdOfQ_aem_J3-ByVAbN-7o7YV6mTTozg   SHOW US SOME LOVE BY SUBSCRIBING TO OUR PATREON! patreon.com/KeepingUpWithTheNerds   We partnered with Dubby to bring you your new favorite energy drink!  Check out dubby.gg and use code "KEEPUPNERD" for 10% off your next order.   A first for The Nerds, week 2 of Month of Guest brings Rachel Elese! Animator, artist and One Piece enjoyed, Rachel and The Nerds discuss animation, her up and comings and recently finished projects she has worked on.  From animating backgrounds for the Teenage Mutant Ninja Turtles, to painting enchanted art for Lorcana, Rachel's time on the show is an eye opening interview into an extremely apperciated world of art and animation.      This Issue is Brought to You by: Bryan Quevedo, Rene Bravo & Nick Valero   Podcasts can also be found here! YouTube: https://tinyurl.com/y6luw7uq Spotify: https://tinyurl.com/y4q64run Apple Podcasts: https://tinyurl.com/y4ztkn2o   Follow us on our socials! Instagram: https://www.instagram.com/keepingwiththenerds/ Twitter: https://twitter.com/KeepitNerds Ask us questions and leave us a like and comment! Don't forget to subscribe and leave a follow!

Episode Title: The Story of Elijah: Faith and Obedience (1 Kings 17:1–16)Episode Description:In this episode, Pastor Ben Smith dives into the story of Elijah, exploring faith and obedience in the face of hardship. From confronting King Ahab's sin to experiencing God's miraculous provision through nature and the unlikely generosity of a widow, this sermon reveals how God works through faithful obedience.Listeners will discover three key truths:1. God provides for obedience – He meets the needs of those who follow Him, often in unexpected ways.2. Suffering is part of life in a fallen world – Trials do not indicate God's absence, but create opportunities for His glory to shine.3. Faith is proven through obedience – True belief is demonstrated through action, even when it is difficult or costly.Through Elijah's story and a personal testimony from Pastor Ben's life, this episode encourages believers to trust God fully, obey His commands, and witness His power in the midst of life's challenges.Scripture Reference: 1 Kings 17:1–16Keywords: Elijah, Faith, Obedience, God's Provision, Trials, Trust in God, Christian Living, SermonSpeaker: Pastor Ben SmithSeries: Heroes of the Faith: The Story of ElijahFormat: Expository SermonFind Out More:Ben Smith is the pastor of Central Baptist Church, Waycross, GA.Additional podcasts, books, and downloadable PDFs of Pastor Ben's sermon outlines and manuscripts are available at http://bensmithsr.org.You can find information about Central Baptist Church at cbcwaycross.org.This sermon was originally preached on January 26, 2020.

For patients with aortic stenosis, is earlier intervention beneficial? Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, and Bernard Prendergast discuss.

In this episode I talk about inner healing of a soul part that didn't trust God, a day when electricity went out, confronting my stepmom's unwise decisions, and the ring on my spirit's index finger.

We're diving into the deep end of storytelling with Ben Brostoff, author of Trials: A Novel of Olympic Swimming Dreams and Redemption. It's a swimming novel for swimmers written by one. Trials follows three swimmers — Hunter Banks, Connor Mahoney, and Miles Green — whose lives are intertwined by one defining moment: the 2004 Olympic Trials, where all three break the world record in the 400 IM. What follows is a two-decade journey through triumph and heartbreak, doping scandals, supersuits, world records, marriage, loss, and the relentless chase of a dream that refuses to die.

The ARRIVE Trial and the Term Breech Trial reshaped modern birth practices in ways researchers never intended. From skyrocketing inductions to the loss of vaginal breech training, these studies reveal how even “gold-standard” science can miss the human side of birth.Clara invites you to take a mindful pause: to look beyond the data, question how evidence gets translated into policy, get curious about how the research was designed, and remember that true evidence-based care must center the individual—not just the research.You'll Learn:What the ARRIVE Trial and the Term Breech Trial actually found (and what they didn't)How these studies shifted policy, practice, and training worldwideWhy over-reliance on “evidence” can erase skills, intuition, and personal choiceHow to bring mindfulness into your decision-making about induction, breech birth, or any medical recommendationWhy traditional and holistic birth practices still matter—even if they've never been studiedMindful Reflection“Mindfulness isn't about ignoring evidence—it's about pausing long enough to ask, ‘Does this research apply to me, in my body, in this context?' True evidence-based care is a dialogue between research, clinician experience, and your own wisdom.”Resources MentionedDownload Clara's Free Birth Plan Template, used at over 5,000 births.Ready for an evidence based birth class? Check out A Path to A Powerful BirthThe Birth Advocacy Toolkit is a great option for expectant parents who have already taken a class but want to make sure their preferences are heard and want evidence based information to help make their decisions. Evidence Based Birth: Evidence on the ARRIVE Trial and Elective Induction at 39 WeeksEvidence Based Birth: Evidence on Breech BirthGrobman WA, et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. NEJM, 2018.Evidence Based Birth: “Evidence on the ARRIVE Trial and Elective Induction at 39 Weeks.”Nethery E, et al. Obstet Gynecol, 2023. Post-ARRIVE induction impact study.Hannah ME, et al. Planned Cesarean vs Planned Vaginal Birth for Breech. Lancet, 2000.Kotaska A. BMJ, 2004. “Inappropriateness of RCTs for complex intrapartum phenomena.”Goffinet F, et al. PREMODA Study. Am J Obstet Gynecol, 2006.RCOG Green-top Guideline No. 20b (2017).ACOG Committee Opinion No. 745 (2018).SOGC No. 384 (2019).Get 20% off your first monthly subscription with NEEDED Vitamins 

Justice Denied, But She's Still Pursuing It: Kristin Louise DuncombeOur guest this week, Kristin Louise Duncombe, describes this week the horror of the molestation she suffered as a preteen girl at the hands of an American diplomat who was also her best friend's father.Even after her abuser was exposed, he was not brought to justice by the American government for decades — and still, to this day, never for his abuse of Kristin. That's why she's still fighting to bring her story to light.To explore Beyond the Crucible resources, including our free Trials-to-Triumphs Self-Assessment, visit beyondthecrucible.com.Enjoy the show? Leave a review on your favorite podcast app and leave a comment at our YouTube channel and be sure subscribe and tell your friends and family about us.Have a question or comment? Drop us a line at info@beyondthecrucible.com

This week on the show, Maine and Josh preview the 2025 ADCC North American championships, also known as the East Coast trials. We take a look at all of the divisions and talk about the most notable athletes registered for the event.We take a look at the under 66 kg divisions followed by the under 77 kg division followed by the under 88 kg division followed by the under 99 kg division followed by the over 99 kg division for the men.Then we take a look at the women's divisions in the under 55 kg division then the under 65 kg division and then the over 65 kg division.We discussed the change in bracket sizing for this event that is notably, much smaller than the trials have been previously. We discussed some of the greater landscape of the sport and the event as a whole that Maine will be live at this coming week.Recorded 11-9-2025

More gambling scandals, tribute to some fallen athletes and potential competition for the WNBA. Lebron James gets a well-deserved shout out.

Greetings Bucketheads!Trials of the Darksaber is an awesome episode and I'm so excited to talk with you about it!Strap on your buckets, let's go!Please follow the show at:Mando_Vision on Twitter and Instagram. Email: MandoVisionTom@gmail.comPlease, like, subscribe and share the show with your friends on all of your favorite podcast platforms and if you can take the time to write a 5-Star review, it will be read on the show! Thank for all the support, please stay safe and take care of each other. Music by Dirty Sweet and used with permission.All audio clips from any “Star Wars” material is copyright of Disney Enterprises Inc. and is only used for the sole purpose of promotion of Disney property and to provide context for talking points. Mando Vision is copyright Thomas Pritchard 2025. ★ Support this podcast on Patreon ★

In this week's reading, Jesus delivers some shocking revelations about the temple and prophetic visions of what's to come. Peter Walsh, Elizabeth Garnsey, and John Kennedy explain how the disciples would have their faith tested, if these prophecies came to pass, and why many people today are still focused on the events Jesus described. Plus, how do we respond when power pushes back against our desire to follow Jesus' ways?Questions for Further Discussion:Themes and Application1. The clergy discuss cycles of violence and the futility of responding to violence with violence. How does this shape our understanding of discipleship today?2. How does the nonviolent approach Jesus models in Luke 21 relate to modern conflicts and social justice work?3. Peter mentions that “endurance” and bearing witness are central to this teaching. What does it mean to “gain your soul” through endurance in the face of chaos?Personal Reflection1. What “temples” or institutions in your own life do you feel attached to that could fall, and how might your faith guide your response?2. Elizabeth talks about tuning into the divine through lived experience and acts of justice. How do you personally recognize when an action aligns with God's ways?3. How does understanding the imperishable nature of the soul affect your approach to challenges, loss, or societal chaos?Broader Spiritual Considerations1. How do you interpret the references to “wars and insurrections” and natural disasters in a modern context? Are these warnings meant literally, metaphorically, or both?2. The hosts discuss the tension between loving tradition and challenging it. How can one honor spiritual traditions while also embracing necessary transformation?3. How does this passage and discussion inspire hope amid fear and uncertainty in our current world?Want to have your question or comment featured on the podcast? Leave a voicemail on our Rev'd Up hotline! Call (203) 442-5002.Learn more about St. Mark's at https://www.stmarksnewcanaan.org

In a live conversation on YouTube, Lawfare Editor in Chief Benjamin Wittes sat down with Lawfare Senior Editors Anna Bower, Molly Roberts, Roger Parloff and Eric Columbus to discuss the criminal trial of the man who threw a sandwich at a federal immigration officer in D.C., a hearing in the prosecution of James Comey, litigation over the conditions of an immigration detention center in Illinois, and more.You can find information on legal challenges to Trump administration actions here. And check out Lawfare's new homepage on the litigation, new Bluesky account, and new WITOAD merch.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

In 1905, eight-year-old Kenneth Beasley, the son of North Carolina State Senator Samuel Beasley, walked out of his one-room schoolhouse in Poplar Branch, Currituck County—and vanished. What followed was one of the most haunting and controversial cases in North Carolina history. A bitter feud between two respected families, a trial built on circumstantial evidence, and a man's death that left more questions than answers. Over a century later, the disappearance of the senator's son remains unsolved. In this episode of Southern Mysteries, explore the loss, suspicion, and silence that still echo through the story of Kenneth Beasley—a mystery that has never let go of the Carolina coast. Join the Community on Patreon: Want more Southern Mysteries? You can hear the Southern Mysteries show archive of 60+ episodes along with Patron exclusive podcast, Audacious: Tales of American Crime and more when you become a patron of the show. You can immediately access exclusive content now at patreon.com/southernmysteries

Jackie Orena is the granddaughter of Victor "Little Vic" Orena, who was allegedly the acting boss of the Colombo crime family according to federal prosecutors. Today, Victor is 91 years old, experiencing significant health issues, and is still serving what is effectively a life sentence in federal prison.This conversation does not glorify organized crime or the past. Instead, it focuses on the deeply human side of this story — what it means to watch a loved one grow old behind bars. Jackie opens up about the emotional and generational weight of the Orena name, the realities of aging in the prison system, and why she and her family are fighting for compassionate release. She talks about the day-to-day challenges her grandfather faces due to his age and health, and what it feels like to hope for mercy in a system that often does not bend. #OrenaFamily #CompassionateRelease #AgingInPrison #PrisonReform #TrueCrimeStories #FamilyLegacy #LockedInWithIanBick #realconversations Thank you to ExpressVPN for sponsoring this episode: Secure your online data TODAY by visiting https://www.expressvpn.com/lockedin to find out how you can get up to four extra months. Connect with Jackie Orena: Instagram: @freelittlevic @jackkieo Website: Www.freelittlevic.com Hosted, Executive Produced & Edited By Ian Bick: https://www.instagram.com/ian_bick/?hl=en https://ianbick.com/ Shop Locked In Merch: http://www.ianbick.com/shop Timestamps: 00:00 Intro — The Cost of Being Labeled “Informant” 05:55 Meet Jackie Orena — Growing Up in the Middle of It 08:10 What It's Like When Your Family Is Incarcerated 13:40 Arrests, Trials, and Watching Your Family Be Torn Apart 20:25 Carrying the Stigma at School & in Public 25:00 Visiting Loved Ones Behind Bars — The Reality 29:40 Learning to Adapt & Finding Identity Beyond the Name 32:00 Her Grandfather at 91 — The Physical and Emotional Decline 37:00 The Mental Toll That Never Gets Talked About 41:50 Injustice, Corruption & What the System Doesn't Want to Admit 47:00 Advocacy & Fighting for Compassionate Release 52:00 Why Elderly Incarceration Needs Reform Now 56:00 Hope, Healing & Rebuilding a Future 59:00 Advice for Families Living With This Weight 01:00:00 Final Reflections & Gratitude for the Conversation Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textJoin Dr. Daphna Yasova Barbeau as she kicks off The Incubator's live coverage from the Children's Hospitals Neonatal Consortium (CHNC) 2025 Symposium in Denver. This opening episode sets the stage for two days of conversations focused on improving care for high-risk infants through data sharing, collaboration, and quality improvement across Level IV NICUs. Daphna introduces the mission behind CHNC and its powerful Children's Hospitals Neonatal Database (CHND)—a resource driving benchmarking and innovation nationwide. Tune in for context, purpose, and the energy that fuels this year's meeting before diving into interviews with CHNC leaders and attendeesSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

(00:00:00) Galactic Influences and Supermoons: Exploring Earth's Crust and Taikonaut Trials (00:00:42) Earth's geology written in the stars (00:10:30) Taikonauts stranded in space following space junk impact (00:12:38) Biggest Supermoon of the year (00:14:59) The Science Report (00:17:20) Skeptics guide to jogging big foots In this episode of SpaceTime, we delve into fascinating intersections of geology and astronomy that could reshape our understanding of Earth's history and the cosmos.Earth's Geology Written in the StarsA groundbreaking study reveals a compelling connection between the structure of our Milky Way galaxy and the evolution of Earth's crust. Researchers from Curtin University have found that meteorite impacts, influenced by the solar system's journey through the galaxy, have played a significant role in shaping our planet's geology. The episode explores how ancient zircon crystals are providing a unique archive of Earth's interactions with the galaxy, suggesting that astrophysical processes may have directly influenced the continents beneath our feet and the conditions that made life possible.Taikonaut Stranded in SpaceIn a dramatic turn of events, three Chinese taikonauts are stranded in orbit after their Shenzhou 20 spacecraft was struck by suspected space junk just hours before their scheduled return to Earth. This segment discusses the implications of the impact, the ongoing assessments by mission managers, and the potential need for a replacement capsule to ensure the crew's safe return. The episode also reflects on past incidents involving space debris and the measures taken to protect the Tiangong Space Station.The Biggest Supermoon of the YearSkywatchers around the globe were treated to the biggest supermoon of the year, appearing 7% larger and 30% brighter than a typical full moon. This segment explains the science behind the phenomenon, including the moon's elliptical orbit and its impact on tides. We also discuss how the term "supermoon" became popularised and the frequency of such lunar events, with several more supermoons on the horizon.www.spacetimewithstuartgary.com✍️ Episode ReferencesPhysical Reviewhttps://journals.aps.org/pr/Naturehttps://www.nature.com/Become a supporter of this podcast: https://www.spreaker.com/podcast/spacetime-your-guide-to-space-astronomy--2458531/support.Earth's Geology Written in the StarsTaikonaut Stranded in SpaceThe Biggest Supermoon of the YearEarth's Geology Written in the StarsTaikonaut Stranded in SpaceThe Biggest Supermoon of the Year

Acts 20:13-38   13 But going ahead to the ship, we set sail for Assos, intending to take Paul aboard there, for so he had arranged, intending himself to go by land. 14 And when he met us at Assos, we took him on board and went to Mitylene.15 And sailing from there we came the following day opposite Chios; the next day we touched at Samos; and the day after that we went to Miletus. 16 For Paul had decided to sail past Ephesus, so that he might not have to spend time in Asia, for he was hastening to be at Jerusalem, if possible, on the day of Pentecost.        17 Now from Miletus he sent to Ephesus and called the elders of the church to come to him. 18And when they came to him, he said to them: "You yourselves know how I lived among you the whole time from the first day that I set foot in Asia, 19 serving the Lord with all humility and withtears and with trials that happened to me through the plots of the Jews; 20 how I did not shrink from declaring to you anything that was profitable, and teaching you in public and from house to house, 21testifying both to Jews and to Greeks of repentance toward God and of faith in our Lord Jesus Christ.22 And now, behold, I am going to Jerusalem, constrained by the Spirit, not knowing what will happen to me there, 23 except that the Holy Spirit testifies to me in every city that imprisonment andafflictions await me. 24 But I do not account my life of any value nor as precious to myself, if only I may finish my course and the ministry that I received from the Lord Jesus, to testify to the gospel ofthe grace of God. 25 And now, behold, I know that none of you among whom I have gone aboutproclaiming the kingdom will see my face again. 26 Therefore I testify to you this day that I am innocent of the blood of all, 27 for I did not shrink from declaring to you the whole counsel of God.28 Pay careful attention to yourselves and to all the flock, in which the Holy Spirit has made youoverseers, to care for the church of God, which He obtained with His own blood. 29 I know that after my departure fierce wolves will come in among you, not sparing the flock; 30 and from among your own selves will arise men speaking twisted things, to draw away the disciples after them. 31Therefore be alert, remembering that for three years I did not cease night or day to admonish every one with tears. 32 And now I commend you to God and to the word of His grace, which is able tobuild you up and to give you the inheritance among all those who are sanctified. 33 I coveted no one's silver or gold or apparel. 34 You yourselves know that these hands ministered to my necessities and to those who were with me. 35 In all things I have shown you that by working hard in this way we must help the weak and remember the words of the Lord Jesus, how He Himself said, 'It is more blessed to give than to receive.'"        36 And when he had said these things, he knelt down and prayed with them all. 37 And there was much weeping on the part of all; they embraced Paul and kissed him, 38 being sorrowful most of all because of the word he had spoken, that they would not see his face again. And they accompanied him to the ship.   Key Words: Humility, Tears, Trials, Teaching, Constrained, Guard, Wolves, Give Keystone Verses: Pay careful attention to yourselves and to all the flock, in which the Holy Spirit has made you overseers, to care for the church of God, which He obtained with His own blood. (Acts 20:28) It is more blessed to give than to receive. (Acts 20:35)     Download Bulletin

Pastor Drew Zylstra preaches from Matthew 24:15-24, “Facing Trials Well.” —————————— More from […]

SouthCrest Church Sunday message, 11/9/25. Our journey through the Bible has us welcoming trials in James 1:1-18. Senior Pastor Matt McFadden explores these verses to guide our understand that trials and suffering should be welcomed as tools used by God to mature and strengthen us as Christians.

Midlake Takes a Walk: Inside the Making of Their Atmospheric Folk So Join us for an intimate conversation with Eric Pulido from Midlake, the critically acclaimed band from Denton, Texas known for their lush, atmospheric folk rock sound. Eric opens up about their creative process, the evolution of their music from The Trials of Van Occupanther to their latest work, and how the landscapes of Texas have shaped their distinctive sound. In this episode of Takin’ a Walk, we explore: • The band’s journey from indie obscurity to international acclaim • Behind-the-scenes stories from recording their most beloved albums • Their collaborative process and the challenges of keeping a band together over two decades • What’s next for Midlake and their evolving musical direction Whether you’re a longtime fan or discovering their music for the first time, this candid conversation offers rare insight into one of indie folk’s most compelling acts. Midlake’s intricate harmonies, pastoral melodies, and 70s-inspired production have earned them a devoted following—now hear the stories behind the songs. Takin A Walk is part of The IHeart Podcast Network and proudly celebrates the fine art of storytelling.Support the show: https://takinawalk.com/See omnystudio.com/listener for privacy information.

Big verdicts grab headlines—but they don't build billion-dollar brands. Digger Earles reveals how discipline, data, and brand strategy power Laborde Earles' growth across Louisiana. From leveraging NIL partnerships for instant credibility to intake systems that close 95% of wanted leads, every move connects trial results to market dominance.  You'll learn: How to turn courtroom wins into peer referrals (and long-term B2B leverage) Using name, image, and likeness to create instant B2C credibility Intake that performs: openers/closers, on-call lawyer assists, and scheduled client touchpoints that reduce inbound noise The settlement-committee system that pushes past “good enough” offers If you like what you hear, hit subscribe. We do this every week. Get Social! Personal Injury Mastermind (PIM) powered by Rankings.io is on Instagram | YouTube | TikTok

We revisit the U.S. 2000 Olympic Trials where the selection committee's athlete rep REFUSED to certify the team and USAG announced the team anyway!  The 2000 U.S. Olympic Trials  This week, we have a group commission from Brianna, Stephanie, Atwood, Laura, Karla, and Emma, all about [deep breath] the collective nightmare that was the 2000 Olympic Trials. We discuss: The gymnasts: Elise Ray, Amy Chow, Kristen Maloney, Morgan White, Jamie Dantzscher, Vanessa Atler, Dominique Dawes, Alyssa Beckerman, Tasha Schwikert, Rachel Tidd, Jeanette Antolin, Amanda Stroud, Shannon Miller The breaking news that there actually was official selection criteria, and it was technically followed. The significance of 2000 Trials as the worst thing that has ever happened ever, the controversy of the selection process, the low point this represented in athlete-first commentary, and just…the Bela of it all Shannon's comeback What if Atler had been able to compete on the "new" vault? The way the commentators talk about Alyssa Beckerman The infamous Rybacki fluff piece DLO + Punch front Shannon's vault injury BEIGE DRAPES Steve Nunno's performance piece The Moceanu sadness forest Why they selected the team they did, and was it the right call? RELATED EPISODES The History of Olympic Trials Controversies Shannon Miller Interview Part 1 Shannon Miller Interview 2015 part 2 Vanessa Atler Jamie Dantzscher Interview How to Stage a Gymnastics Protest Tokyo Olympics Recap SUPPORT OUR WORK Club Gym Nerd: Join Here Commission an episode  Add exclusive Club Content like College & Cocktails to your favorite podcast player (instructions here) Headstand Game: Play Now Forum: Start Chatting Merch: Shop Now Thank you to our Sponsor: Huel Daily Greens Ready to Drink – Get 15% off your purchase for New Customers with our exclusive code GYMCASTIC at https://huel.com//GYMCASTIC. Use our code and fill out the post checkout survey to help support the show! CHAPTERS - pre-auto ad insertion 00:00 – Introduction: Jakarta Worlds  and Sleep Deprivation Update 03:29 – About : One of Our Most Popular Episodes 05:12 – Show Intro: The Nightmare That Was the 2000 Olympic Trials 08:10 – Format Overview: 6-5-4 and Why It Mattered 11:27 – The "Selection Criteria Is F***ing Shocking" Breakdown 16:42 – Who Was on the Selection Committee (and Why That's a Problem) 21:08 – Setting the Scene: Panic After 1996, Comebacks, and Chaos 25:50 – Significance: One of the Worst Selection Decisions Ever 30:31 – Day 1 Begins: "This Will Be Bela's Team" 33:52 – Jamie Dantzscher on Bars: The "Bela Fixed Jamie" Narrative 36:59 – Morgan White Isn't OK 39:40 – Shannon Miller on Bars and Vault: Injuries and "Good Catch by Nunno" 43:52 – Vanessa Atler's Vault: What If She'd Had the Table? 47:16 – Alyssa Beckerman Commentary: Moral Failings ≈ Missed Skills 50:08 – The Rybacki / Dantzscher / Atler Fluff: Coaching Betrayals 52:33 – Weird-Ass Shannon Miller "Party Time" Fluff 53:55 – Huel Daily Greens Ad: The Vitamin Redemption Arc 57:03 – Atler's Floor and the Scoring Face That Said It All 59:49 – Atler's Terrifying Beam Dismount and the "Nightmare Walrus" 1:03:14 – Day 2: Shannon's Vault Injury and Bela/Nunno/Nassar on Deck 1:08:55 – The Beige Drapes Fluff: Bela as Star of the Show 1:13:29 – Atler Bars Semi-Miss and Nunno's Performance Piece 1:17:12 – "Alternates Are Not Ranked" – The Policy Loophole 1:20:43 – Atler's Day 2 Vault Downgrade and Implications 1:24:02 – The Wildly Inappropriate Morgan White Body Commentary 1:28:21 – Tasha Schwikert Appears: "Mom and Dad Are Dealers" 1:31:09 – More Beckerman Disrespect and MLT Quotes of the Year 1:34:38 – Moceanu Fluff: Clawing at the Tree in the Sadness Forest 1:38:12 – Amy Chow's Calm Dominance on Day 2 1 :42:07 – Final Scores and Who Actually Hit 1:46:04 – Final Team Selection Disaster and Tracee Talavera's Refusal to Sign RESOURCES Jakarta Worlds Headquarters page The Balance Beam Situation: Spencer's GIF Code of Points Gymnastics History and Code of Points Archive from Uncle Tim Kensley's men's gymnastics site Neutral Deductions RESISTANCE RESOURCES > here